Form 8-K - Current report:
SEC Accession No. 0001104659-25-033200
Filing Date
2025-04-09
Accepted
2025-04-09 07:00:47
Documents
13
Period of Report
2025-04-09
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2511880d1_8k.htm   iXBRL 8-K 140723
  Complete submission text file 0001104659-25-033200.txt   329717

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA avte-20250409.xsd EX-101.SCH 3020
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE avte-20250409_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avte-20250409_pre.xml EX-101.PRE 22362
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2511880d1_8k_htm.xml XML 3810
Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40544 | Film No.: 25823806
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)